Investors: Purchases Of CBD Product Maker’s Stock Were Domestic Transactions

(June 12, 2020, 9:34 AM EDT) -- BROOKLYN, N.Y. — Dismissal of claims in a securities class action lawsuit against a manufacturer of cannabidiol (CBD) products and others is not warranted because although the over-the-counter (OTC) exchange in which the company’s stock was traded does not constitute a domestic exchange under the U.S. Supreme Court’s ruling in Morrison v. National Australia Bank Ltd., investors’ purchase of the company’s stock were domestic transactions, shareholders argue in a June 4 opposition brief filed in New York federal court (In re Curaleaf Holdings Inc. Securities Litigation, No. 19-4486, E.D. N.Y.)....